Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk

Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk
复制标题

DOI:
10.1126/scitranslmed.aai9048
复制
发表时间:
2017-11-15
影响因子:
17.1
通讯作者:
Savai, Rajkumar
Savai, Rajkumar
中科院分区:
医学1区
文献类型:
--
作者:
Pullamsetti, Soni Savai;Kojonazarov, Baktybek;Savai, Rajkumar

文献摘要

被引文献

相似文献

呼吸困难是晚期肺癌的一种常见、毁灭性且知之甚少的症状。在我们的队列中,在519例接受计算机断层扫描诊断肺癌的患者中,250例平均肺动脉直径>28 mm,表明肺动脉高压(PH)。在人肺癌组织中,我们始终观察到血管重塑和血管周围炎性细胞积聚(巨噬细胞/淋巴细胞)增加。在三种肺癌小鼠模型(LLC 1、KRas(LA 2)和cRaf-BxB)中模拟血管重塑、PH和血管周围炎性细胞积聚。相反,NOD。Cg-Prkdc(scid)Il 2 rgtm 1 Wjl/SzJ免疫缺陷异种移植物和显性阴性IKK 2突变体三重转基因(Sftpc-rtTA/Tet-O-Ikk 2DN)小鼠没有发展PH。将人肺癌细胞与巨噬细胞和淋巴细胞共培养强烈上调细胞因子释放,引起增强的迁移、凋亡抗性和磷酸二酯酶5(PDE 5)介导的人肺血管细胞的上调,这是PH的典型特征。PDE 5抑制剂西地那非在LLC 1模型中极大地抑制了PH。我们得出结论,肺癌相关PH代表了一种独特的PH类别;靶向微环境中的炎症和PDE 5提供了一种潜在的治疗选择。
Dyspnea is a frequent, devastating, and poorly understood symptom of advanced lung cancer. In our cohort, among 519 patients who underwent a computed tomography scan for the diagnosis of lung cancer, 250 had a mean pulmonary artery diameter of >28 mm, indicating pulmonary hypertension (PH). In human lung cancer tissue, we consistently observed increased vascular remodeling and perivascular inflammatory cell accumulation (macrophages/ lymphocytes). Vascular remodeling, PH, and perivascular inflammatory cell accumulation were mimicked in three mouse models of lung cancer (LLC1, KRas(LA2), and cRaf-BxB). In contrast, NOD. Cg-Prkdc(scid) Il2rgtm1Wjl/SzJ immunodeficient xenograft and dominant-negative IKK2 mutant triple transgenic (Sftpc-rtTA/Tet-O-Ikk2DN) mice did not develop PH. Coculturing human lung cancer cells with macrophages and lymphocytes strongly up-regulated cytokine release, provoking enhanced migration, apoptosis resistance, and phosphodiesterase 5 (PDE5)-mediated up-regulation of human lung vascular cells, which are typical features of PH. The PDE5 inhibitor sildenafil largely suppressed PH in the LLC1 model. We conclude that lung cancer-associated PH represents a distinct PH category; targeting inflammation in the micro-environment and PDE5 offers a potential therapeutic option.